Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.

Abstract

Anoikis is a type of programmed cell death induced by loss of anchorage to the extracellular matrix (ECM). Anoikis resistance (AR) is crucial for the survival of metastatic cancer cells in blood, lymphatic circulation and distant organs. Compared to ordinary cancer cells, anoikis resistant cancer cells undergo various cellular and molecular alterations, probably characterizing the cells with unique features not limited to anoikis resistance. However, the molecular mechanisms connecting anoikis resistance to other metastatic properties are still poorly understood. Here, the biological interaction between anoikis resistance and angiogenesis as well as their involvement into peritoneal metastasis of gastric cancer (GC) were investigated in vitro and in vivo. The prognostic value of key components involved in this interaction was evaluated in the GC cohort. Compared to ordinary GC cells, GCAR cells exhibited stronger metastatic and pro-angiogenic traits corresponding to elevated PDGFB secretion. Mechanistically, transcription factor C/EBPβ facilitated PDGFB transcription by directly binding to and interacting with PDGFB promoter elements, subsequently increasing PDGFB secretion. Secreted PDGFB promoted the survival of detached GC cells through a C/EBPβ-dependent self-feedback loop. Moreover, secreted PDGFB promoted angiogenesis in metastases via activation of the MAPK/ERK signaling pathway in vascular endothelial cells. Both C/EBPβ activation level and PDGFB expression were significantly elevated in GC and correlated with metastatic progression and poor prognosis of patients with GC. Overall, interaction between GCAR cells and vascular endothelial cells promotes angiogenesis and peritoneal metastasis of GC based on C/EBPβ-mediated PDGFB autocrine and paracrine signaling. C/EBPβ-PDGFB-PDGFRβ-MAPK axis promises to be potential prognostic biomarkers and therapeutic targets for peritoneal metastasis of GC.

• Authors: Shangce Du, Zhi Yang, Xiaofeng Lu, Suhail Yousuf, Min Zhao, Wenxi Li, Ji Miao, Xingzhou Wang, Heng Yu, Xinya Zhu, Hong Chen, Linseng Shi, En Xu, Xuefeng Xia, Wenxian Guan
• Journal: Oncogene (Oncogene) Vol. 40 Issue 38 Pg. 5764-5779 (09 2021) ISSN: 1476-5594 [Electronic] England
• PMID: 34341514 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Chemical References

• CCAAT-Enhancer-Binding Protein-beta
• CEBPB protein, human
• Proto-Oncogene Proteins c-sis

Topics

• Animals
• Anoikis
• Autocrine Communication
• CCAAT-Enhancer-Binding Protein-beta (metabolism)
• Cell Line, Tumor
• Drug Resistance, Neoplasm
• Gene Expression Regulation, Neoplastic
• Humans
• Mice
• Neoplasm Transplantation
• Paracrine Communication
• Peritoneal Neoplasms (blood supply, metabolism, pathology, secondary)
• Prognosis
• Promoter Regions, Genetic
• Proto-Oncogene Proteins c-sis (genetics, metabolism)
• Stomach Neoplasms (blood supply, genetics, metabolism, pathology)
• Up-Regulation